window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 13, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Medical devices

  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Medical devices

    12th Day of Christmas: Ledger Run and AcuityMD predict AI will drive operational change across clinical trials and MedTech in 2026

    On the 12th Day of Christmas in Discover Pharma’s industry [...]

    May 5, 2026
  • Clinical & Regulatory,Medical devices,Therapeutic Areas

    Study highlights laser device that could delay knee replacement surgery

    A newly published study has introduced a minimally invasive laser [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Medical devices,Therapeutic Areas

    FDA approves first at-home non-drug treatment for depression

    US regulators have authorised the first at-home brain-stimulation treatment for [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Medical devices,Therapeutic Areas

    Appleton blood centre adopts Reveos automation to boost platelet supply

    The Community Blood Center (CBC) in Appleton, Wisconsin has adopted [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Medical devices,Therapeutic Areas

    Neuraxpharm and mjn-neuro plan launch of digital solution for early detection of epileptic seizures

    Neuraxpharm and mjn-neuro are preparing to launch a digital health [...]

    May 5, 2026
  • Digital & Data,Medical devices,Therapeutic Areas

    India continuous glucose monitoring market set for steady growth to 2035

    India’s market for continuous glucose monitoring (CGM) devices is expected [...]

    May 5, 2026
  • Drug Delivery & Formulation,Drug Discovery & Development,Medical devices,Pharmaceuticals and therapeutics

    ACG wins Red Dot Design Award for personalised medicine concept

    ACG, a leading provider of solid-dosage solutions, has received the [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Drug Discovery & Development,Medical devices,Pharmaceuticals and therapeutics

    Paris-based Tulyp Medical seeks FDA clearance following initial clinical use of perfusion device

    Tulyp Medical, a Paris-based medtech startup, has emerged from stealth [...]

    May 5, 2026
  • Central Nervous System,Clinical & Regulatory,Drug Discovery & Development,Medical devices,Pharmaceuticals and therapeutics

    Owlstone Medical awarded up to $49.1 million from ARPA-H to develop at-home multi-cancer early detection tests

    Owlstone Medical has received an award of up to $49.1 [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Medical devices,Pharmaceuticals and therapeutics

    Xeltis reports positive EU key trial results for aXess, showing superior patency and safety in hemodialysis

    Xeltis’ aXess EU key trial shows sustained patency, fewer interventions, [...]

    May 5, 2026
Previous234Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
  • NICE expands Lokelma access for hyperkalaemia after draft recommendation
    Categories: Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • Oncodesign expands ARRONAX deal to secure astatine-211 supply for radiotherapy research
    Categories: Biotech & Pharma Business, Drug Discovery & Development, Manufacturing & Supply Chain, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top